Glomerulosclerosis, Focal Segmental
5 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Apecotrep for glomerulosclerosis, focal segmental | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Brivekimig for glomerulosclerosis, focal segmental | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Frexalimab for glomerulosclerosis, focal segmental | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for glomerulosclerosis, focal segmental | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Rilzabrutinib for glomerulosclerosis, focal segmental | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |